OPRX - OptimizeRx Corporation
| Previous Close | 13.78 |
| Open | 14.17 |
| Bid | 13.04 x 800 |
| Ask | 13.30 x 800 |
| Day's Range | 12.71 - 14.82 |
| 52 Week Range | 1.43 - 18.39 |
| Volume | 56,202 |
| Avg. Volume | 63,278 |
| Market Cap | 160.865M |
| Beta (3Y Monthly) | 0.99 |
| PE Ratio (TTM) | 665.00 |
| EPS (TTM) | 0.02 |
| Earnings Date | May 11, 2017 - May 12, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.92 |
- GlobeNewswire•2 days ago
OptimizeRx Survey Shows Providers Want to Engage with Patients on Drug Costs for Adherence and Improved Care
OptimizeRx Corp. (OPRX), a leading digital health messaging platform for the pharmaceutical industry , released its full results and findings from its Drug Cost Survey. The cost of prescription drugs is on the mind of physicians and patients alike.
- GuruFocus.com•10 days ago
OptimizeRx Corp (OPRX) Files 10-K for the Fiscal Year Ended on December 31, 2018
OptimizeRx Corp is a technology solutions company serving the healthcare industry. OptimizeRx Corp had annual average EBITDA growth of 23.90% over the past ten years. Warning! GuruFocus has detected 2 Warning Signs with OPRX.
- Thomson Reuters StreetEvents•13 days ago
Edited Transcript of OPRX earnings conference call or presentation 26-Feb-19 9:30pm GMT
Q4 2018 OPTIMIZERx Corp Earnings Call
- GlobeNewswire•18 days ago
OptimizeRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019; Pre-Conference Webcast Available March 11
OptimizeRx Corp. (OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at the 31st Annual ROTH Conference being held at The Ritz Carlton, Laguna Niguel in Orange County, California, on March 17-19, 2019. Last year, the ROTH Conference hosted close to 550 participating companies and more than 4,700 attendees, including institutional investors, analysts, family offices and high net worth investors. The network has become the largest of its kind, now reaching more than half of the ambulatory patient market in the U.S.
- GlobeNewswire•24 days ago
OptimizeRx Reports Fourth Quarter 2018 Results; Net Revenue Up 64% to a Record $6.6 Million, Driving First Profitable Year
ROCHESTER, Mich., Feb. 26, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.
- Simply Wall St.•last month
Should We Be Cautious About OptimizeRx Corporation’s (NASDAQ:OPRX) ROE Of 0.6%?
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! While some investors are already well versed in financial metricsRead More...
- GlobeNewswire•last month
OptimizeRx Sets Fourth Quarter and Full Year 2018 Conference Call for Tuesday, February 26, 2018 at 4:30 p.m. ET
ROCHESTER, Mich., Feb. 13, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call.
- GlobeNewswire•last month
OptimizeRx Survey Shows Providers Believe They Have a Role in Discussing Care Costs with Patients
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, announced today its initial findings from a physician survey focused on prescription drug costs.
- GlobeNewswire•last month
OptimizeRx Introduces OptimizeMDs, a “Voice of the Physician” Multi-Specialty Digital Health Panel
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has formed OptimizeMDs, a multi-specialty physician panel with the mission of improving the effectiveness of digital health communications delivered throughout the care continuum. “OptimizeRx provides technology designed to streamline and improve communications between pharma/life sciences, providers and patients,” said Miriam Paramore, president of OptimizeRx.
- American City Business Journals•2 months ago
OptimizeRx partners with IllumiCare
OptimizeRx Corp., a digital health messaging company, for the pharmaceutical industry, has formed a partnership with Birmingham's IllumiCare. IllumiCare’s Smart Ribbon platform will feature a new app from OptimizeRx that presents drug-savings opportunities that health providers and the clinical care team can distribute to the patient directly at the point-of-care. “Our collaboration with OptimizeRx will enable providers to be better stewards of health care spending,” said G.T. LaBorde, CEO of IllumiCare. “Our Smart Ribbon technology, accessible within the provider’s workflow in the electronic health record (EHR), will give providers easy access to render coupons, savings opportunities or alternate drug choices to best support the patient.” IllumiCare offers a non-intrusive electronic medical record tool that provides clinicians with patient-specific information ranging from real-time costs of procedures to predicted patient harm data.
- GlobeNewswire•2 months ago
OptimizeRx Announces New Partnership with Health IT Pioneer lllumiCare
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, announced a new partnership with IllumiCare, a pioneer in point-of-care healthcare information technology that saves hospitals millions annually. IllumiCare's Smart Ribbon® platform will feature a new app from OptimizeRx, the RxSavings App, to present drug savings opportunities—such as co-pay offers and vouchers—that providers and the clinical care team can distribute to the patient directly at the point-of-care.
- Simply Wall St.•2 months ago
Does Market Volatility Impact OptimizeRx Corporation’s (NASDAQ:OPRX) Share Price?
If you own shares in OptimizeRx Corporation (NASDAQ:OPRX) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of Read More...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of OPRX earnings conference call or presentation 5-Nov-18 9:30pm GMT
Q3 2018 OPTIMIZERx Corp Earnings Call
- GlobeNewswire•3 months ago
OptimizeRx Announces Pricing of Public Offering of Common Stock
OptimizeRx Corporation (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering by WPP Luxembourg Gamma Three S.à r.l., a shareholder of OptimizeRx, of 2,103,702 shares of OptimizeRx common stock, at a public offering price of $10.00 per share. In connection with the offering, OptimizeRx granted the underwriters a 30-day option to purchase up to an additional 315,555 newly issued shares of common stock from the Company at the public offering price less the underwriting discount and commissions. The offering is expected to close on or about December 20, 2018, subject to customary closing conditions.
- GlobeNewswire•3 months ago
OptimizeRx Announces Proposed Public Offering of Common Stock
OptimizeRx Corporation (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed underwritten public offering by WPP Luxembourg Gamma Three S.à r.l., a shareholder of OptimizeRx, of 2,103,702 shares of OptimizeRx common stock. In connection with this offering, OptimizeRx expects to grant the underwriters a 30-day option to purchase up to an additional 315,555 newly issued shares of common stock from the Company at the public offering price less the underwriting discount and commissions.
- GlobeNewswire•4 months ago
OptimizeRx Joins MSCI USA Microcap Index
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, joined the MSCI USA Microcap Index at the conclusion of the MSCI indexes semi-annual reconstitution, effective after the U.S. market closes today, according to the MSCI website. “Joining the MSCI USA Microcap Index represents another major market milestone for OptimizeRx after our up-listing to Nasdaq earlier this year,” said OptimizeRx CEO, William Febbo.
- ACCESSWIRE•4 months ago
OptimizeRx to Present at 11th Annual LD Micro Main Event on December 4-6, 2018
ROCHESTER, MI / ACCESSWIRE / November 28, 2018 / OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 11th Annual LD Micro Main Event institutional investor conference being held on December 4-6, 2018 at the Luxe Sunset Bel Air Hotel in Bel Air, California. William Febbo, CEO of OptimizeRx, is scheduled to present on Tuesday, December 4, at 1:30 p.m. Pacific time, with one-on-one meetings with institutional analysts and investors. The presentation will be also webcast live and available for replay here and via the investor relations section of the company's website at www.optimizerx.com.
- Simply Wall St.•4 months ago
Do Institutions Own OptimizeRx Corporation (NASDAQ:OPRX) Shares?
The big shareholder groups in OptimizeRx Corporation (NASDAQ:OPRX) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership Read More...
- GlobeNewswire•4 months ago
Recent Analysis Shows Construction Partners, OptimizeRx, OncoMed Pharmaceuticals, Issuer Direct, Red Violet, and Golden Minerals Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Nov. 15, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- GlobeNewswire•5 months ago
OptimizeRx Reports Third Quarter 2018 Results; Net Revenue Up 75% to a Record $5.4 Million, Driving $0.02 EPS
ROCHESTER, Mich., Nov. 05, 2018 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.
- Zacks•5 months ago
OptimizeRx (OPRX) Q3 Earnings Preview: What to Look Out For
OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
